Sorbent raises $17 million

Sorbent Therapeutics Inc. (Sunnyvale, Calif.) raised $17 million in a series B round. New investor AgeChem Venture Fund joined existing investors CMEA Capital; Arch Venture Partners; Sofinnova Ventures; and Dow Chemical Co. (NYSE:DOW). ...